Following the spinoff of Baxter International's biotech business, CEO Robert Parkinson faces a battle to convince the market of the company's stand-alone prospects.
Ameet Sachdev, Chicago Tribune: Business
Wed, 07/01/2015 - 2:47pm
Following the spinoff of Baxter International's biotech business, CEO Robert Parkinson faces a battle to convince the market of the company's stand-alone prospects.